FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ian Friedland

Research Profile

Chemicals & Drugs

Disorders

Procedures

Physiology

Bacterial Drug Resistance

Living Beings

Co-author Network

Publications

TOP 3
Mark J DiNubile; Ian R Friedland; Christina Y Chan; Mary Motyl; Hilde Giezek; Kathleen McCarroll; Malathi Shivaprakash; John P Quinn; Robert A Weinstein; Joseph W Chow
Bowel colonization with vancomycin-resistant enterococci after antimicrobial therapy for intra-abdominal infections: observations from 2 randomized comparative clinical trials of ertapenem therapy.
S V Yakovlev; L S Stratchounski; Gail L Woods; Ben Adeyi; Kathleen McCarroll; J A Ginanni; Ian R Friedland; C A Wood; Mark J DiNubile
Ertapenem versus cefepime for initial empirical treatment of pneumonia acquired in skilled-care facilities or in hospitals outside the intensive care unit.
Mark J DiNubile; Ian R Friedland; Christina Y Chan; Mary Motyl; Hilde Giezek; Malathi Shivaprakash; Robert A Weinstein; J P Quinn
Bowel colonization with resistant gram-negative bacilli after antimicrobial therapy of intra-abdominal infections: observations from two randomized comparative clinical trials of ertapenem therapy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ian Friedland (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Mark J DiNubile; Ian R Friedland; Christina Y Chan; Mary Motyl; Hilde Giezek; Kathleen McCarroll; Malathi Shivaprakash; John P Quinn; Robert A Weinstein; Joseph W Chow
Bowel colonization with vancomycin-resistant enterococci after antimicrobial therapy for intra-abdominal infections: observations from 2 randomized comparative clinical trials of ertapenem therapy.
Diagnostic microbiology and infectious disease 2007;58(4):491-4.
2006: S V Yakovlev; L S Stratchounski; Gail L Woods; Ben Adeyi; Kathleen McCarroll; J A Ginanni; Ian R Friedland; C A Wood; Mark J DiNubile
Ertapenem versus cefepime for initial empirical treatment of pneumonia acquired in skilled-care facilities or in hospitals outside the intensive care unit.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2006;25(10):633-41.
2005: Mark J DiNubile; Ian R Friedland; Christina Y Chan; Mary Motyl; Hilde Giezek; Malathi Shivaprakash; Robert A Weinstein; J P Quinn
Bowel colonization with resistant gram-negative bacilli after antimicrobial therapy of intra-abdominal infections: observations from two randomized comparative clinical trials of ertapenem therapy.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2005;24(7):443-9.
2005: Joseph W Chow; Vilas Satishchandran; Theresa A Snyder; Charlotte M Harvey; Ian R Friedland; Mark J DiNubile
In vitro susceptibilities of aerobic and facultative gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2002 Study for Monitoring Antimicrobial Resistance Trends (SMART).
Surgical infections 2005;6(4):439-48.
2004: Ian R Friedland; G Gallagher; T King; Gail L Woods
Antimicrobial susceptibility patterns in Pseudomonas aeruginosa: data from a multicenter Intensive Care Unit Surveillance Study (ISS) in the United States.
Journal of chemotherapy (Florence, Italy) 2004;16(5):437-41.
2004: Hedy Teppler; Richard M Gesser; Ian R Friedland; Gail L Woods; Anne R Meibohm; Gary A Herman; Goutam C Mistry; Robin Isaacs
Safety and tolerability of ertapenem.
The Journal of antimicrobial chemotherapy 2004;53 Suppl 2():ii75-81.
2004: Guillermo Ortiz-Ruiz; Norbert Vetter; Robin Isaacs; Alexandra D Carides; Gail L Woods; Ian R Friedland
Ertapenem versus ceftriaxone for the treatment of community-acquired pneumonia in adults: combined analysis of two multicentre randomized, double-blind studies.
The Journal of antimicrobial chemotherapy 2004;53 Suppl 2():ii59-66.
2004: Ian R Friedland; Kathleen McCarroll; Mark J DiNubile; Gail L Woods
Ertapenem as initial antimicrobial monotherapy for patients with chronic obstructive pulmonary disease hospitalized with typical community-acquired pneumonia.
Pulmonary pharmacology & therapeutics 2004;17(4):199-203.
2003: Gail L Woods; Robin D Isaacs; Kathleen McCarroll; Ian R Friedland
Ertapenem therapy for community-acquired pneumonia in the elderly.
Journal of the American Geriatrics Society 2003;51(11):1526-32.
2003: Ian R Friedland; Lue Stinson; Margaretmary Ikaiddi; Sandra Harm; Gail L Woods
Resistance in Enterobacteriaceae: results of a multicenter surveillance study, 1995-2000.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2003;24(8):607-12.
2003: Ian R Friedland; Lue Stinson; Margaretmary Ikaiddi; Sandra Harm; Gail L Woods
Phenotypic antimicrobial resistance patterns in Pseudomonas aeruginosa and Acinetobacter: results of a Multicenter Intensive Care Unit Surveillance Study, 1995-2000.
Diagnostic microbiology and infectious disease 2003;45(4):245-50.
2002: Ian R Friedland; Lori A Mixson; Anup Majumdar; Mary Motyl; Gail L Woods
In vitro activity of ertapenem against common clinical isolates in relation to human pharmacokinetics.
Journal of chemotherapy (Florence, Italy) 2002;14(5):483-91.
2002: Barbara A Pelak; Gail L Woods; Hedy Teppler; Ian R Friedland; Ken Bartizal; Mary Motyl
Comparative in-vitro activities of ertapenem against aerobic bacterial pathogens isolated from patients with complicated intra-abdominal infections.
Journal of chemotherapy (Florence, Italy) 2002;14(3):227-33.
2002: Ian R Friedland; Robin Isaacs; Lori A Mixson; Mary Motyl; Gail L Woods
Use of surrogate antimicrobial agents to predict susceptibility to ertapenem.
Diagnostic microbiology and infectious disease 2002;43(1):61-4.
2002: Guillermo Ortiz-Ruiz; Jose Caballero-Lopez; Ian R Friedland; Gail L Woods; Alexandra D Carides
A study evaluating the efficacy, safety, and tolerability of ertapenem versus ceftriaxone for the treatment of community-acquired pneumonia in adults.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;34(8):1076-83.